英文摘要 |
Using adjuvant chemotherapy to prevent cancer recurrence in patients with early breast cancer is not absolute. With the development of precision medicine, gene expression profiling tests can be used as an indication for breast cancer patients to consider receiving chemotherapy. Inconsistent results on improving women's decision-making conflict required further examination. Systematic review and meta-analysis was conducted. The primary purpose was to 1) understand the effectiveness of gene expression profiling tests in the decision-making conflict about adjuvant chemotherapy for early breast cancer women, and 2) to examine the effectiveness of decision-making conflict according to the risk level by recurrence scores. The secondary purpose was examined the effectiveness of gene expression profiling tests on the state anxiety. Studies published before June 2021were searched. The database includes Embase, MEDLINE, Cochrane Library and other sources such as google scholar. Study quality was assessed using CASP (Critical Appraisal Skills Programme) and statistical analyses were performed using comprehensive meta-analysis version 2 software. A total of 11 studies were include, all of which were single-group pre and post-test studies. The results of meta-analysis showed that gene expression profiling tests can effectively improve decision-making conflicts (fixed mode SMD=-0.204, p<0.001; random mode SMD=-0.224, p<0.001) and state anxiety (SMD=-0.180, p<0.001). Sub-group analysis showed that the improved decision-making conflict in the high-risk group was much more compared to the low-risk group. However, state anxiety decreased was only observed in the low-risk group. |